Graham Wood

Altasciences Co., Inc. engages in the provision of clinical pharmacology development services. It offers bioanalysis and research services, preclinical services, clinical services, and development programs. The company was founded in 1992 and is headquartered in Laval, Canada.

Part of LMC Diabetes & Endocrinology Ltd., Manna Research, Inc. has over 20 years of experience providing research trials across almost every therapeutic area. The private company is based in Montréal, Canada. Through clinical research, the Canadian company's work has improved health for tens of millions of people worldwide. The company offers research opportunities and resources for stress management, mindful eating, and grocery shopping. Additionally, they have expanded their services to include dermatology research. Manna Research was acquired by LMC Diabetes & Endocrinology Ltd. on March 12, 2015.

Cetero Research is an industry leading contract research organization (CRO) in early phase research services. With more than 25 years of experience from its founding companies, Cetero has conducted more than 10,000 clinical pharmacology studies – more than any other CRO. Cetero’s proven track record allows the company to provide flexible and high quality drug development services, and its time-tested systems produce consistent and reliable data Cetero’s clients can trust. Cetero’s clinical research expertise consists of traditional early-stage, healthy-volunteer clinical pharmacology and bioavailability studies, as well as specialty Phase Ia/b trials in patients. Its bioanalytical services support clinical, preclinical drug and biomarker analysis for small and large molecules. In addition, Cetero owns and operates a full-scale central laboratory supporting Phase I-IV clinical trials in North and South America.